comparemela.com

Latest Breaking News On - Zacks medical services - Page 1 : comparemela.com

Elevance Health Stock Jumps 6 1%: Will It Continue to Soar?

Elevance Health (NYSE:ELV) shares ended the last trading session 6.1% higher at $538.48. The jump came on an impressive volume with a higher-than-.

Zacks medical servicesElevance healthHealth benefitsAnnual strategic decisions conferenceZacks rank

Elevance Health Stock Jumps 6 1%: Will It Continue to Soar? - Teladoc Health (NYSE:TDOC), Elevance Health (NYSE:ELV)

Elevance Health (NYSE: ELV) shares ended the last trading session 6.1% higher at $538.48. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 3.5% loss over the past four weeks.

Elevance healthZacks medical servicesHealth benefitsAnnual strategic decisions conferenceZacks rank

The Oncology Institute, Inc Reports Q1 Loss, Lags Revenue Estimates - Icecure Medical (NASDAQ:ICCM), Oncology Institute (NASDAQ:TOI)

The Oncology Institute, Inc Reports Q1 Loss, Lags Revenue Estimates - Icecure Medical (NASDAQ:ICCM), Oncology Institute (NASDAQ:TOI)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Oncology instituteOncology institute incZacks medical servicesIcecure medical ltdZacks consensus estimateZacks rankZacks industry rankMedical servicesCure medical

Icon PLC (ICLR) Q4 Earnings Surpass Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.58% and 0.87%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks medical servicesDiagnostics incIcon plcWhile iconZacks investment researchZacks consensus estimateZacks rankStrong buyZacks industry rankMedical servicesZacks investmentZacks rankQuarterly earningsStimate revisionsPs estimatesOnsensus estimate

InnovAge Holding Corp (INNV) Reports Q4 Loss, Tops Revenue Estimates

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -200% and 1.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks investment researchWhile innovage holding corpImmunoprecise antibodies ltdInnovage holding corpZacks medical servicesInnovage holdingZacks consensus estimatePage holdingZacks rankStrong buyZacks industry rankMedical servicesZacks medicalImmunoprecise antibodiesPrecise antibodiesZacks investment

vimarsana © 2020. All Rights Reserved.